AU Stock MarketDetailed Quotes

ATXOA Amplia Therapeutics Ltd

Watchlist
  • 0.012
  • -0.003-20.00%
20min DelayTrading May 1 10:07 AET
4.66MMarket Cap0.00P/E (Static)

About Amplia Therapeutics Ltd Company

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Company Profile

SymbolATXOA
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067 03 9415 4000

Company Executives

  • Name
  • Position
  • Salary
  • Christopher John Burns
  • Non Executive Director,Chief Executive Officer,Managing Director
  • --
  • Warwick Bonner Tong
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Robert Peach
  • Non-Executive Director
  • --
  • Jane Catherine Bell
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More